Ratio To Fine-Tune Radioligand Approach In Cancer With Trillium And Macropa Platforms

Emerging Company Profile: Ratio Therapeutics
Ratio's Trillium Platform Helps Enhance Radioligand PK • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs